Literature DB >> 33778739

Confirmatory MRI-guided Biopsy Following Positive Transrectal US-guided Biopsy Results in Improved Risk Stratification and Treatment Planning for Newly Diagnosed Prostate Cancer.

Clifford R Weiss1, Alex J Solomon1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 33778739      PMCID： PMC7983734          DOI： 10.1148/rycan.2020200130

Source DB:  PubMed          Journal:  Radiol Imaging Cancer        ISSN： 2638-616X


× No keyword cloud information.
  9 in total

Review 1.  Overdiagnosis and overtreatment of prostate cancer.

Authors:  Stacy Loeb; Marc A Bjurlin; Joseph Nicholson; Teuvo L Tammela; David F Penson; H Ballentine Carter; Peter Carroll; Ruth Etzioni
Journal:  Eur Urol       Date:  2014-01-09       Impact factor: 20.096

Review 2.  MR Imaging-Guided Focal Treatment of Prostate Cancer: An Update.

Authors:  Sherif G Nour
Journal:  Radiol Clin North Am       Date:  2017-12-12       Impact factor: 2.303

Review 3.  PI-RADS Steering Committee: The PI-RADS Multiparametric MRI and MRI-directed Biopsy Pathway.

Authors:  Anwar R Padhani; Jelle Barentsz; Geert Villeirs; Andrew B Rosenkrantz; Daniel J Margolis; Baris Turkbey; Harriet C Thoeny; François Cornud; Masoom A Haider; Katarzyna J Macura; Clare M Tempany; Sadhna Verma; Jeffrey C Weinreb
Journal:  Radiology       Date:  2019-06-11       Impact factor: 11.105

4.  Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in the Detection of Clinically Significant Prostate Cancer in the Prostate Imaging Reporting and Data System Era: A Systematic Review and Meta-analysis.

Authors:  Niranjan J Sathianathen; Altan Omer; Eli Harriss; Lucy Davies; Veeru Kasivisvanathan; Shonit Punwani; Caroline M Moore; Christof Kastner; Tristan Barrett; Roderick Cn Van Den Bergh; Ben A Eddy; Fergus Gleeson; Ruth Macpherson; Richard J Bryant; James W F Catto; Declan G Murphy; Freddie C Hamdy; Hashim U Ahmed; Alastair D Lamb
Journal:  Eur Urol       Date:  2020-05-20       Impact factor: 20.096

5.  In-Bore MRI-guided Prostate Biopsies in Patients with Prior Positive Transrectal US-guided Biopsy Results: Pathologic Outcomes and Predictors of Missed Cancers.

Authors:  Kareem K Elfatairy; Christopher P Filson; Martin G Sanda; Adeboye O Osunkoya; Sherif G Nour
Journal:  Radiol Imaging Cancer       Date:  2020-09-25

6.  Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study.

Authors:  Marloes van der Leest; Erik Cornel; Bas Israël; Rianne Hendriks; Anwar R Padhani; Martijn Hoogenboom; Patrik Zamecnik; Dirk Bakker; Anglita Yanti Setiasti; Jeroen Veltman; Huib van den Hout; Hans van der Lelij; Inge van Oort; Sjoerd Klaver; Frans Debruyne; Michiel Sedelaar; Gerjon Hannink; Maroeska Rovers; Christina Hulsbergen-van de Kaa; Jelle O Barentsz
Journal:  Eur Urol       Date:  2018-11-23       Impact factor: 20.096

7.  Cancer statistics, 2020.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2020-01-08       Impact factor: 508.702

Review 8.  MR-Guided Prostate Interventions.

Authors:  David A Woodrum; Krzysztof R Gorny; Lance A Mynderse
Journal:  Top Magn Reson Imaging       Date:  2018-06

Review 9.  Comparing Three Different Techniques for Magnetic Resonance Imaging-targeted Prostate Biopsies: A Systematic Review of In-bore versus Magnetic Resonance Imaging-transrectal Ultrasound fusion versus Cognitive Registration. Is There a Preferred Technique?

Authors:  Olivier Wegelin; Harm H E van Melick; Lotty Hooft; J L H Ruud Bosch; Hans B Reitsma; Jelle O Barentsz; Diederik M Somford
Journal:  Eur Urol       Date:  2016-08-25       Impact factor: 20.096
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.